Neurocrine Biosciences, Inc.
(NASDAQ : NBIX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-0.25%281.561.4%$839.54m
AMGNAmgen, Inc.
-0.47%219.821.3%$513.32m
CELGCelgene Corp.
-0.13%109.881.3%$466.17m
GILDGilead Sciences, Inc.
-1.78%63.911.0%$393.21m
VRTXVertex Pharmaceuticals, Inc.
-0.82%208.081.9%$311.32m
ILMNIllumina, Inc.
-1.01%302.913.5%$308.19m
REGNRegeneron Pharmaceuticals, Inc.
-1.57%339.472.6%$263.49m
EXASEXACT Sciences Corp.
0.22%82.2324.0%$210.24m
ALXNAlexion Pharmaceuticals, Inc.
-0.70%107.612.0%$178.54m
SGENSeattle Genetics, Inc.
0.95%115.856.1%$138.27m
BMRNBioMarin Pharmaceutical, Inc.
0.25%75.234.3%$123.95m
SRPTSarepta Therapeutics, Inc.
-0.42%97.0514.6%$114.89m
AAgilent Technologies, Inc.
-0.60%77.791.6%$100.75m
NBIXNeurocrine Biosciences, Inc.
1.74%115.025.0%$91.98m
BGNEBeiGene Ltd.
-3.03%192.252.1%$85.95m

Company Profile

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.